Try our Advanced Search for more refined results

Expert Analysis

A Reminder For Drug Cos. To Confirm Orange Book Listings

By Tasha Francis Gerasimow, Devora Allon and Jeanna Wacker (October 11, 2023, 6:19 PM EDT) -- On Sept. 14, the Federal Trade Commission released a policy statement, supported by the U.S. Food and Drug Administration, warning pharmaceutical companies that make and sell brand-name drugs that they could face legal action if they improperly list patents in the FDA's Approved Drug Products with Therapeutic Equivalence Evaluations, more commonly known as the Orange Book. ...

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Attached Documents

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!